Approved Study Database

Ref. No. Scientific Title Principal investigator
2022.354 An investigation of air dispersion pattern and the environmental influence of open airway suction in general ward setting and identification of a practical enclosure device for open airway suction in general ward. Ms. TO YUK LING
杜玉玲
2018.159 Endoscopic retrograde cholangiopancreatography (ERCP) in older patients: is age a risk factor for complications? Dr. TO Tsz Yan
杜芷茵
2018.478 Situation of idiopathic pulmonary fibrosis in Hong Kong --- a 5 year retrospective epidemiology study Dr. TO Kin Wang
杜建宏
2020.034 Prospective study to evaluate Stretococcus pneumoniae serotype prevalence in community acquired pneumonia in Hong Kong using a urinary kit Dr. TO Kin Wang
杜建宏
2019.025 A validation study of a portable monitoring device for diagnosing obstructive sleep apnea in patients with co-existing medical illnesses Dr. TO Kin Wang
2014.556 Application of GeneXpert on bronchoscopic samples in the clinical management of patients suspicious of Tuberculosis Dr. TO Kin Wang
2016.661 Validation of a novel device for screening patients with symptoms of obstructive sleep apnea Dr. TO Kin Wang
杜建宏
2016.737 Mortality among Tuberculosis patients in Hong Kong Dr. TO Kin Wang
杜建宏
2013.689 A cross over case control study using a vibration positional device for treatment of position dependent obstructive sleep apnea Dr. TO Kin Wang
2011.243 Defining nasal respiratory tissue biomarkers for diagnosis and monitoring of latent TB in patients with rheumatological diseases. (cross sectional study, with reference to interferon-gamma release assay) Dr. TO Kin Wang
2012.037 Comparison of Nasal Positive End Expiratory Pressure valve to dental device as an alternative treatment for OSA Dr. To Kin Wang
2008.193 A Cross Sectional Study of Prevalence of Sleep Disordered Breathing in Patients on HAART in a HIV Clinic in Hong Kong Dr To Kin Wang
2011.109 A cross sectional study to define the profile of nasal respiratory tissue biomarkers in a different respiratory diseases. Dr To Kin Wang
杜建宏
2009.562 MicroRNA-mediated regulation of the multidrug resistance transporter ABCG2 Prof. To Kin Wah
2010.254 Prognostic value of ABCG2 and its modulation by microRNAs in AML Professor To Kin Wah
2012.079 Epigenetic downregulation of the xenobiotic transporter ABCG2 as a predisposing factor for diet-induced colorectal cancer development Professor To Kin Wah
2012.064 Epigenetic down-regulation of the xenobiotic transporter ACG2 - a predisposing factor for colorectal cancer development and a novel target for cancer prevention? Professor To Kin Wah
2010.034 Clinical relevance of microRNA dysregulation and DNA methylation in mediating overexpression of ABCG2 in chemo-resistant colorectal cancer Professor To Kin Wah
2013.161 Xenobiotic transporter ABCG2: Regulatory role in the initiation and progression of colorectal cancer Professor To Kin Wah
2011.155 Novel prognostic biomarkers for predicting response to chemotherapy in colorectal cancer Professor To Kin Wah
2011.034 Exploiting regulation of the drug transporter ABCG2 for personalized treatment with the HMG-CoA reductase inhibitors (Statins) Prof. To Kin Wah
2010.398 Novel prognostic markers for predicting response to chemotherapy in colorectal cancer Professor To Kin Wah
2013.577 Identification of genetic and epigenetic biomarkers for the detection of bladder cancer in urine and blood plasma Prof. To Ka-Fai
杜家輝
2014.315 The effect of educational-based adherence intervention on adherence of inhalation therapy, disease control, quality of life and healthcare utilization among patients with chronic obstructive pulmonary disease: a randomized controlled trial, pilot study Ms To Ka Wing
2006.133 Epigenetic Silencing of CXCL14 and Its in Vitro/in Vivo Modulation of Dendritic Cell in Nasopharyngeal Carcinoma Prof. To Ka Fai
2014.143 Establishment of a primary cell culture platform of human solid cancers to facilitate molecular and functional studies Prof. To Ka Fai
2006.278 Identification of Epstein-Barr Virus miRNA in Nasopharyngeal Carcinoma Cells Prof. TO Ka Fai
2014.070 Investigating the genomic landscape of lung cancer Prof. TO Ka Fai
2014.700 Study on the role of Esptein-Barr Virus (EBV)-encoded microRNAs in controlling DNA damage repairs in EBV-associated nasopharyngeal carcinoma Prof. TO Ka Fai
2016.585 A Multi-Center Retrospective Observational Study to Evaluate PD-L1 Protein Expression in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Prof. TO Ka Fai
杜家輝教授
2017.096 Characterization of oncogenic role of BCL3 in Epstein-Barr virus associated nasopharyngeal carcinoma Dr. TO Ka Fai
杜家輝
2014.077 Hippo signaling/miR-15a and 16 -YAP1-CTGF Regulatory Cascade Promotes Gastric Cancer Progression Prof To Ka Fai
2016.231 Target inhibition of ATM-mediated homologous recombination repair by Epstein-Barr virus miR-BARTs in nasopharyngeal carcinoma: molecular mechanisms and clinical implications Dr. TO Ka Fai
杜家輝
2023.625 The identification of the replication initiation factor MCM10 as a target of YAP1/TEAD4 that drives cancer stemness and drug resistance in gastric cancer Prof. TO Ka Fai
2024.013 The identification of complex variants in lung cancer genomes by long-read sequencing Prof. TO Ka Fai
2020.409 Molecular signature of different histological subtypes of lung adenocarcinoma Prof. TO Ka Fai
2020.118 Developing the next generation sequencing approach to distinguish multiple primary lung cancers from intrapulmonary metastases Dr. TO Ka Fai
杜家輝
2009.521 Characterization of YAPI as a function oncogene in gastric cancer Prof. To Ka Fai
2005.129 Epigenetic Silencing of DOC2-hDAB2 and Tumor Suppressor Activity of DOC2-hDAB2 in Nasopharyngeal Carcinoma Prof. To Ka Fai
2012.119 Elucidating the role of tumor suppressive non-coding RNA MEG3 in nasopharyngeal carcinoma Prof To Ka Fai
2011.140 Identification the cellular target of Epstein-Barr virus encoded miRNAs in nasopharyngeal carcinoma by RISC immunoprecipitation assay Prof. To Ka Fai
2009.522 Characterization of Epstein-Barr virus induced genetic and epigenetic alterations in cholangiocarcinoma cells Prof. To Ka Fai
2008.167 Systemic Identification of Epstein-Barr Virus Encoded MicroRNAs Functions in Nasopharyngeal Carcinoma by Integrated Computational and Experimental Approaches Prof. To Ka Fai
2012.159 Identification of cancer-specific fusion genes in colorectal cancer Prof. To Ka Fai
2011.153 Functional characterization of putative oncogene YAP1 in gastric cancer Prof To Ka Fai
2009.195 Targeting Tumor Suppressor DLEC1 by ebv-mir-BART7 and its Role in Carcinogenesis of Nasopharyngeal Carcinoma Prof. To Ka Fai
2005.174 Sequencing Analysis of 3' Region of cagA Gene in Helicobacter Pylori Isolated from Hong Kong Chinese Patients with Different H. Pylori-associated Diseases Prof. TO Ka Fai
2012.020 Detection of Oncogenic Driver Mutation in Non-small Cell Lung Cancer Prof. To Ka Fai
2004.152 Characterization of Epstein Barr Virus Status and Genetic Alterations in Squamous Cell Carcinoma of Nasopharynx and Other Head and Neck Regions Prof. TO Ka Fai
2011.157 Transcriptome-wide profiling of microRNA in H. pylori-infected gastric epithelial cells: insight into the host-pathogen interaction Prof. To Ka Fai

Page 61 of 289.